Purpose: To evaluate the efficacy and safety of transepithelial crosslinking for halting the progression of keratoconus. Methods: Uncorrected and corrected visual acuity, simulated keratometry, corneal topography and pachymetry data were evaluated at baseline and 1 year after bilateral transepithelial crosslinking using ParaCel™ and the KXL™ device (Avedro, Waltham, Massachusetts, US). Results: The keratometry, uncorrected visual acuity, best corrected visual acuity at the baseline and after 1 year of follow-up was stable and even 
Keratoconus is a non-inflammatory cone-like ectasia of the cornea, which is usually bilateral and progresses over time with consequent central and paracentral thinning of the stroma and irregular astigmatism.
The only known treatment for arresting the progression of the keratoconus is collagen corneal crosslinking, which enforces a human cornea and links the collagen with means to rejuvenate the corneal tissue. The two most widespread techniques for crosslinking are EPI-ON (transepithelial crosslinking protocol) and EPI-OFF (crosslinking with epithelium removal).
The main advantages of the transepithelial (TE) crosslinking technique over the traditional technique are that it is pain free with no stromal oedema and provides the possibility to treat both eyes at the same session. It also has the morphological advantages of reducing the rate of death of keratocytes and the number of endothelial cells. 1 With the improvement of this technique it could be the standard treatment for keratoconic patients. The patient was then booked for TE crosslinking, which is the usual practice in our institute and took place at the end of January 2013. We performed osmotic crosslinking using ParaCel™ riboflavin developed by Dr Roberto Pinelli, which comprises 0.25 % riboflavin, methyl cellulose, hypotonic NaCl and benzalklonium chloride produced by Avedro Watham, together with the KXL device, which was also produced by the same company. The technique was as follows:
Case Report
• Five minutes pre soak;
• Kxl Avedro ultraviolet (UV) A source;
• ParaCel instillation every 20 seconds during UVA exposure;
• 2.40 minutes timing of exposure;
• 45 mW/cm 2 ; and
• Pulsed UVA emission.
The patient was checked immediately and at the end of the day for any eventual complications, 1 which thus far we have never had. He 
Results
From the results of visual acuity and keratometry of this case we can see the improvement of the visual acuity plus the decrease and the stabilisation of the keratometry of the this patient over 1-year follow-up.
Discussion
Corneal collagen crosslinking is already a well-established clinical treatment, which was originally indicated for ectatic corneal lesions such as keratoconus, pellucid marginal degeneration and ectasia post excimer laser refractive surgery. 2 The main streams in the treatment are the Dresden protocol or EPI-OFF with all the pros and cons 2, 3 and the EPI-ON that has gained wide development over the years. [4] [5] [6] [7] Debate continues as to whether the TE is effective and durable compared with the Dresden protocol. In our practice we use the Osmotic TE with Paracel and KCL device and the results 6 have thus far been very good. There are also several other surfactant riboflavin solutions 8 
